Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors. Mr Grau has been a …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

